Paul van Slyke
Chief Tech/Sci/R&D Officer at PHARMADRUG INC.
Profile
Paul van Slyke is currently the Chief Scientific Officer at Pharmadrug, Inc. He previously held the same position at Vasomune Therapeutics, Inc. and Sairiyo Therapeutics, Inc. He obtained a doctorate degree from the University of Toronto.
Paul van Slyke active positions
| Companies | Position | Start |
|---|---|---|
| PHARMADRUG INC. | Chief Tech/Sci/R&D Officer | 2021-05-12 |
Former positions of Paul van Slyke
| Companies | Position | End |
|---|---|---|
Sairiyo Therapeutics, Inc.
 Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Chief Tech/Sci/R&D Officer | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | - |
Training of Paul van Slyke
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMADRUG INC. | Health Technology |
| Private companies | 2 |
|---|---|
Sairiyo Therapeutics, Inc.
Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Health Technology |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Paul van Slyke
